WINIMED 50 (Stanozolol)
• CAS number: 10418-03-8
• Molecular Weight: 328.49 g/mol
• Formula: C21H32N2O
WINIMED 50 by DEUS MEDICAL®
WINIMED 50 (Stanozolol)
Overview
WINIMED 50 (Stanozolol) is a derivative of dihydrotestosterone (DHT). It is used for the treatment of anemia and hereditary angioedema which causes episodes of swelling of the face, extremities, genitals, bowel wall, and throat. It is manufactured as 50mg/ml injections which contain stanozolol 50mg and excipients.
Stanozolol Mechanism of Action
Stanozolol is an anabolic steroid and acts on androgen receptors. Stanozolol has weak androgenic properties which makes it useful in the treatment of children. It also seems to enhance the production of the C1NH protein. Shortage of this protein is implicated in the development of hereditary angioedema. Even though it has weak androgenic properties it can still act on the kidneys to increase erythropoietin which leads to an increase in red cell production.
WINIMED 50 (Stanozolol) Dosage
50mg weekly via the intramuscular route.
Stanozolol Side effects
Hepatotoxicity, increase in weight, acne, mood variation, hirsutism, and postmenopausal bleeding.
Stanozolol Interactions
Anticoagulants, antidiabetic drugs, insulin.
✓ Stanozolol . . . . . . . . . . . . . . . . . . 50mg
✓ Excipients . . . . . . . . . . . . . . . . . . . . . q.s
BECOME A PARTNER
We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.